Detail Information of Xenobiotics-driven Alterations in 3D Complexes
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0003 Transporter Info | ||||
Gene Name | ABCB1 | ||||
Transporter Name | P-glycoprotein 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
Xenobiotic Name | Doxorubicin Drug Info | ||||
Xenobiotic Type | Approved Drug | ||||
MOA | Inhibition | ||||
PubChem CID | 31703 | ||||
Docking Score | -10.193 kcal/mol | ||||
EFMDA Details | EFMDA Info | ||||
Xenobiotic Details | |||||
Formula | C27H29NO11 | ||||
Molecular Weight | 543.5 | ||||
Canonical SMILES |
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O
|
||||
InChI |
InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22+,27-/m0/s1
|
||||
InChIKey | AOJJSUZBOXZQNB-TZSSRYMLSA-N | ||||
Pharmaceutical Properties | Xlogp | 1.3 | Rotatable Bond Count | 5 | |
Hydrogen Bond Donor Count | 6 | Hydrogen Bond Acceptor Count | 12 | ||
Xenobiotic Name | Astemizole Drug Info | ||||
Xenobiotic Type | Drug Withdrawn | ||||
MOA | Inhibition | ||||
PubChem CID | 2247 | ||||
Docking Score | -10.185 kcal/mol | ||||
EFMDA Details | EFMDA Info | ||||
Xenobiotic Details | |||||
Formula | C28H31FN4O | ||||
Molecular Weight | 458.6 | ||||
Canonical SMILES |
COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F
|
||||
InChI |
InChI=1S/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31)
|
||||
InChIKey | GXDALQBWZGODGZ-UHFFFAOYSA-N | ||||
Pharmaceutical Properties | Xlogp | 6 | Rotatable Bond Count | 8 | |
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 5 | ||
Xenobiotic Name | Dihydroergotamine Drug Info | ||||
Xenobiotic Type | Approved Drug | ||||
MOA | Inhibition | ||||
PubChem CID | 10531 | ||||
Docking Score | -10.087 kcal/mol | ||||
EFMDA Details | EFMDA Info | ||||
Xenobiotic Details | |||||
Formula | C33H37N5O5 | ||||
Molecular Weight | 583.7 | ||||
Canonical SMILES |
C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C
|
||||
InChI |
InChI=1S/C33H37N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,17,21,23,25-27,34,42H,7,12-16,18H2,1-2H3,(H,35,39)/t21-,23-,25-,26+,27+,32-,33+/m1/s1
|
||||
InChIKey | LUZRJRNZXALNLM-JGRZULCMSA-N | ||||
Pharmaceutical Properties | Xlogp | 2.4 | Rotatable Bond Count | 4 | |
Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 6 | ||
Pagination
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.